Home Versus Office Biofeedback Therapy for Fecal Incontinence
1 other identifier
interventional
33
1 country
1
Brief Summary
Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with Fecal Incontinence. It is not easily available to the vast majority of patients in the community with this problem. It is therefore imperative that a more pragmatic therapeutic approach that can be administered easily in the community ought to be developed. However, whether a treatment program that is based on home-training can be just as useful as office-based training has not been evaluated. The purpose of this study is to assess whether having patients train their pelvic floor muscles at home is as effective as in-office biofeedback training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 28, 2015
CompletedFirst Posted
Study publicly available on registry
July 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedAugust 6, 2020
August 1, 2020
2.4 years
October 28, 2015
August 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Number of episodes of fecal incontinence
Assess the change in the No of FI episodes between baseline week and end of study week and compare between the two treatment groups. Responder is defined as a patient with greater than 50% reduction in FI episodes after treatment when compared to baseline. Responder rates will compared between the two treatment groups.
six weeks
Secondary Outcomes (4)
Overall quality of life and symptom perception on previously validated Fecal Incontinence questionnaires
six weeks
Anal sphincter pressure and rectal sensation
six weeks
FI severity, quality of life and bowel symptoms
Six weeks
Treatment compliance with home biofeedback
Six weeks
Study Arms (2)
Home Biofeedback
ACTIVE COMPARATORPatients will be given home biofeedback device (InTone) to take home and practice biofeedback exercises at least twice a day for six weeks of therapy. Intervention: Home device biofeedback training.
Office biofeedback
ACTIVE COMPARATORPatients with fecal incontinence will receive traditional office biofeedback, once weekly, over six weeks. Intervention: Regular office biofeedback training with assistance of biofeedback person..
Interventions
Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with anorectal problems. Complete training sessions once a week for 6 weeks in the office.
Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with anorectal problems, but instead of an office therapy, the subject will use a biofeedback device to gain strength in their anorectal muscles. This device will be taught how to use in the first session and then the subject will take it home to complete at least 1 session a day for 6 weeks.
Eligibility Criteria
You may qualify if:
- recurrent episodes of fecal incontinence for six months
- no mucosal disease
- on a two week stool diary patient will report at least one episode of incontinence a week
You may not qualify if:
- severe diarrhea
- on opioids, tricyclics (except on stable doses \> 3months)
- active depression
- comorbid illnesses, severe cardiac disease, chronic renal failure or previous gastrointestinal surgery except cholecystectomy and appendectomy
- neurologic diseases (e.g. head injury, epilepsy, multiple sclerosis, strokes, spinal cord injury)
- impaired cognizance (mini mental score of \< 15) and/or legally blind
- metal implants, pacemakers
- previous pelvic surgery, bladder repair, radical hysterectomy
- ulcerative and Crohn's colitis
- rectal prolapse, anal fissure, anal surgery or inflamed hemorrhoids
- pregnant women or nursing mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Augusta University
Augusta, Georgia, 30907, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Satish Rao, MD, PhD
Augusta University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Everyone is masked to the assignment of home or office biofeedback training. Once the subject makes it to their treatment session, then everyone will know which one the subject has been allocated to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine, Division Chief Fellowship Program Director Director, Digestive Health Center
Study Record Dates
First Submitted
October 28, 2015
First Posted
July 13, 2017
Study Start
October 1, 2015
Primary Completion
March 1, 2018
Study Completion
September 30, 2019
Last Updated
August 6, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share